Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions
The mainstays of glioblastoma treatment, maximal safe resection, radiotherapy preserving neurological function, and temozolomide (TMZ) chemotherapy have not changed for the past 17 years despite significant advances in the understanding of the genetics and molecular biology of glioblastoma. This rev...
Main Authors: | Ashish H. Shah, John D. Heiss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/6/787 |
Similar Items
-
Glioblastoma Treatment: State-of-the-Art and Future Perspectives
by: Alejandro Rodríguez-Camacho, et al.
Published: (2022-06-01) -
Glioblastoma in Elderly Patients: Current Management and Future Perspectives
by: Giuseppe Minniti, et al.
Published: (2019-03-01) -
Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
by: Masoumeh Najafi, et al.
Published: (2023-01-01) -
Factors Affecting Outcome in the Treatment of Glioblastoma
by: Nenad Koruga, et al.
Published: (2021-01-01) -
Novel Treatment Strategies for Glioblastoma
by: Stanley S. Stylli
Published: (2020-10-01)